interleukin-8 and Frontotemporal-Dementia

interleukin-8 has been researched along with Frontotemporal-Dementia* in 2 studies

Reviews

1 review(s) available for interleukin-8 and Frontotemporal-Dementia

ArticleYear
Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders.
    Current HIV/AIDS reports, 2019, Volume: 16, Issue:1

    The aim of this study was to examine the synaptic biomarker neurogranin in cerebrospinal fluid (CSF) in different stages of HIV infection and in relation to what is known about CSF neurogranin in other neurodegenerative diseases.. CSF concentrations of neurogranin are increased in Alzheimer's disease, but not in other neurodegenerative disorder such as Parkinson's disease, frontotemporal dementia, and Lewy body dementia. Adults with HIV-associated dementia have been found to have decreased levels of neurogranin in the frontal cortex, which at least to some extent, may be mediated by the proinflammatory cytokines IL-1β and IL-8. CSF neurogranin concentrations were in the same range for all groups of HIV-infected individuals and uninfected controls. This either indicates that synaptic injury is not an important part of HIV neuropathogenesis or that CSF neurogranin is not sensitive to the type of synaptic impairment present in HIV-associated neurocognitive disorders.

    Topics: Adult; AIDS Dementia Complex; Alzheimer Disease; Biomarkers; Female; Frontal Lobe; Frontotemporal Dementia; HIV Infections; Humans; Interleukin-1beta; Interleukin-8; Lewy Body Disease; Male; Middle Aged; Neurogranin; Parkinson Disease

2019

Other Studies

1 other study(ies) available for interleukin-8 and Frontotemporal-Dementia

ArticleYear
A three-dimensional dementia model reveals spontaneous cell cycle re-entry and a senescence-associated secretory phenotype.
    Neurobiology of aging, 2020, Volume: 90

    A hexanucleotide repeat expansion on chromosome 9 open reading frame 72 (C9orf72) is associated with familial amyotrophic lateral sclerosis (ALS) and a subpopulation of patients with sporadic ALS and frontotemporal dementia. We used inducible pluripotent stem cells from neurotypic and C9orf72+ (C9+) ALS patients to derive neuronal progenitor cells. We demonstrated that C9+ and neurotypic neuronal progenitor cells differentiate into neurons. The C9+ neurons, however, spontaneously re-expressed cyclin D1 after 12 weeks, suggesting cell cycle re-engagement. Gene profiling revealed significant increases in senescence-associated genes in C9+ neurons. Moreover, C9+ neurons expressed high levels of mRNA for CXCL8, a chemokine overexpressed by senescent cells, while media from C9+ neurons contained significant levels of CXCL8, CXCL1, IL13, IP10, CX3CL1, and reactive oxygen species, which are components of the senescence-associated secretory phenotype. Thus, re-engagement of cell cycle-associated proteins and a senescence-associated secretory phenotype could be fundamental components of neuronal dysfunction in ALS and frontotemporal dementia.

    Topics: Amyotrophic Lateral Sclerosis; C9orf72 Protein; Cell Cycle; Cells, Cultured; Cellular Senescence; DNA Repeat Expansion; Frontotemporal Dementia; Gene Expression; Gene Expression Regulation, Developmental; Humans; Induced Pluripotent Stem Cells; Interleukin-8; RNA, Messenger; Stem Cells

2020